Litcius/Paper detail

Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial

Nicholas J. Short, Daniel Nguyen, Elias Jabbour, Jayastu Senapati, Zhihong Zeng, Ghayas C. Issa, Hussein A. Abbas, Cedric Nasnas, Wei Qiao, Xuelin Huang, Gautam Borthakur, Kelly S. Chien, Fadi Haddad, Naveen Pemmaraju, Omer Karrar, Danielle Nguyen, Marina Konopleva, H. Kantarjian, Farhad Ravandi

2024The Lancet Haematology17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVenetoclaxDecitabinePonatinibMyeloid leukemiaMyeloidOncologyInternal medicineLeukemiaDasatinibGeneticsImatinibGene expressionBiologyDNA methylationChronic lymphocytic leukemiaGeneChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia ResearchProtein Degradation and Inhibitors
Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial | Litcius